Cerebral microbleeds aggravate severity of motor function, cognitive and emotional status in Parkinson's disease

Tian Feng1, Hongzhou Zuo1, Xinyi Du1

  • 1Department of Neurology, The First Affiliated Hospital Chongqing Medical University, 400016, Chongqing, China.

Acta Neurologica Belgica
|November 5, 2025
PubMed
Abstract

Insights

Cerebral microbleeds (CMBs) are common in Parkinson's disease (PD). Higher CMB burden is linked to worse motor function and cognitive decline in PD patients, suggesting CMBs may worsen disease severity.

Area of Science:

  • Neurology
  • Neuroimaging
  • Genetics

Background:

  • Cerebral microbleeds (CMBs) are prevalent in Parkinson's disease (PD).
  • The impact of CMBs on PD clinical severity and genetic links is not well understood.
  • This study investigates the association between CMBs and PD severity.

Purpose of the Study:

  • To determine the prevalence of CMBs in PD patients.
  • To identify risk factors associated with CMBs in PD.
  • To examine the relationship between CMB burden and motor, cognitive, and emotional functions in PD.
  • To explore the genetic link between CMBs and PD severity using Mendelian randomization.

Main Methods:

  • Recruited 158 PD patients from Chongqing Medical University.
  • Utilized susceptibility-weighted imaging (SWI) for CMB detection.
  • Performed clinical assessments for motor, cognitive, and emotional function.
  • Conducted genome-wide association study (GWAS) and Mendelian randomization (MR) analyses.

Main Results:

  • 33.5% of PD patients had CMBs.
  • Age, disease duration, and hypertension were risk factors for CMBs.
  • Higher CMB burden correlated with poorer motor function and anxiety.
  • MR analysis indicated genetic susceptibility to CMBs is linked to worse motor function, lower cognitive scores (MoCA, MMSE), and increased dementia risk in PD.

Conclusions:

  • CMBs are common in PD, associated with age, disease duration, and hypertension.
  • Increased CMB burden may exacerbate Parkinson's disease severity.
  • Preliminary MR analysis suggests a potential causal relationship between genetic susceptibility to CMBs and PD severity.